Included In This Lesson
Outline
What is the generic name?
DAROLUTAMIDE
What is the Trade Name for DAROLUTAMIDE?
NUBEQA
What are the Indications for DAROLUTAMIDE?
- 1 INDICATIONS AND USAGE NUBEQA is indicated for the treatment of patients with non-metastatic castration resistant prostate cancer (nmCRPC). NUBEQA is an androgen receptor inhibitor indicated for the treatment of patients with non-metastatic castration-resistant prostate cancer. ( 1 )
View Our Nursing Pharmacology Course
References: https://open.fda.gov/
Other Pharm Resources